Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects

Supplementary Materials
Supplementary Figure S1 : The antitumor abilities of M1 macrophages. (A) Characterization of M1 macrophages derived from RAW264.7 by FACS and real-time PCR. *P < 0.05 vs. control; # P < 0.01 vs. control. (B) MDA-MB-231 D-luciferin induced bioluminescence obtained in mice treated with M1 macrophages derived from RAW264.7 or PBS. Fourteen days after the breast cancer model in nude mice was used to examine the phagocytosis of M1 macrophages by tumor cells, M1-polarized macrophages (5 × 10 6 cells/ mouse) in 100 μl saline (M1 group, n = 6) were injected into the tumor sites. Control animals (Control group, n = 6) underwent the cancer model procedures and only saline was injected. Quantification of the bioluminescent signal in tumors after treatments showed that M1 macrophage-treated mice displayed a significant delay in the tumor growth rate.
# P < 0.05 vs. PBS group. 
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